Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kevin Charles Gorman currently holds 20,604 shares of NEUROCRINE BIOSCIENCES INC (NBIX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kevin Charles Gorman has been a net seller of NBIX stock. They have purchased $1.0K and sold $156.7M worth of shares.
Kevin Charles Gorman's most recent insider trade was on Jun 16, 2026, when they sold 20,604 shares at $0.00 per share.
Kevin Charles Gorman serves as Executive at NEUROCRINE BIOSCIENCES INC (NBIX). They have executed 124 insider transactions totaling $156.7M over their tenure at the company.
Kevin Charles Gorman holds the position of Executive at NEUROCRINE BIOSCIENCES INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Kevin Charles Gorman has shown a selling trading pattern, with $1.0K in total purchases and $156.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kevin Charles Gorman was on May 19, 2026, when they sold $37.8M worth of NBIX shares. This transaction involved 245,088 shares at $154.33 per share.
Kevin Charles Gorman currently owns 20,604 shares of NEUROCRINE BIOSCIENCES INC (NBIX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kevin Charles Gorman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kevin Charles Gorman has 124 Form 4 filings on record as an insider at NEUROCRINE BIOSCIENCES INC.
Set alerts for Kevin Charles Gorman and 40,000+ other insiders.